We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XGN icon
26
Exagen
XGN
$161M
$11.1M 1.07%
1,384,631
ADER
27
DELISTED
26 Capital Acquisition Corp
ADER
$9.88M 0.95%
1,000,000
ODP
28
DELISTED
ODP
ODP
$9.61M 0.93%
209,681
FAZE
29
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$9.24M 0.89%
931,022
+238,322
+34% +$2.37M
TARS icon
30
Tarsus Pharmaceuticals
TARS
$2.97B
$8.99M 0.87%
534,524
+20,235
+4% +$376K
HTZWW
31
Hertz Global Holdings Warrants
HTZWW
$89.4M
$8.78M 0.85%
571,922
+361,291
+172% +$5.1M
BWAY
32
Brainsway
BWAY
$615M
$7.4M 0.71%
1,698,418
-1,096,400
-39% -$4.27M
GBTG icon
33
American Express Global Business Travel
GBTG
$4.94B
$7.37M 0.71%
+740,900
New +$7.33M
ALPAU
34
DELISTED
Alpha Healthcare Acquisition Corp III Units
ALPAU
$6.89M 0.66%
700,000
OYST
35
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$5.93M 0.57%
509,794
PFTA
36
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$5.92M 0.57%
603,512
-33,000
-5% -$320K
SILJ icon
37
Amplify Junior Silver Miners ETF
SILJ
$3.95B
$5.65M 0.54%
401,220
+235,873
+143% +$3.04M
WBD icon
38
Warner Bros
WBD
$67.4B
$5.54M 0.53%
222,200
+100,000
+82% +$2.74M
NOK icon
39
Nokia
NOK
$51B
$5.46M 0.53%
1,000,000
BACA
40
DELISTED
Berenson Acquisition Corp. I
BACA
$5.34M 0.51%
548,201
MSAC
41
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$4.89M 0.47%
+500,000
New +$4.86M
MRNA icon
42
PUT
Moderna
MRNA
$23.9B
$4.54M 0.44%
16,300
BHAC
43
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$4.06M 0.39%
412,600
-10,000
-2% -$98.2K
SNCE
44
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.04M 0.39%
37,766
-1,767
-4% -$277K
JNCE
45
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.9M 0.38%
+574,335
New +$4.09M
DJT icon
46
Trump Media & Technology Group
DJT
$2.6B
$3.55M 0.34%
+55,000
New +$4.14M
CDAQ
47
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$3.49M 0.34%
361,614
-411,814
-53% -$3.97M
MIC
48
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$3.35M 0.32%
899,432
+329,432
+58% +$1.21M
CHNGU
49
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$3.32M 0.32%
46,996
+600
+1% +$40.6K
C icon
50
Citigroup
C
$227B
$3.19M 0.31%
59,749
-5,568
-9% -$344K

Similar funds

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.